STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more

<iframe
  src="https://statesidedaily.com/embed/cluster/b4ae61e167555f0c9f9b4430b2be86a1c4e9068e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about a GSK deal for a drug from China, job losses in the U.S., and more"></iframe>